Enovis (ENOV)

• Market cap: $1.79B
• 1 day: 1.79%
• 5 days: -6.3%
• 1 month: 2.97%
• 3 months: 16.57%
• 6 months: -9.68%
• Year to date: -29.48%
• 1 year: -24.3%
• 5 years: -33.86%
• 10 years: -35.57%
• Sector: Healthcare
• Industry: Medical Devices

About: Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Employees: 7,367